Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Helix BioPharma Corp. HBPCF

Full chart Compare
Set alert

Price alert · HBPCF

All alert types
1.71 USD +0.94 (+122.08%)

At closeOct 30, 2026, 4:00 PM EDT

1.71 Day range 1.71
0.77 52-week range 1.73
YTD
-1.16%
1 year
-1.16%

Financial health

Altman Z-Score

4.50 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -59.9×
FY 2017: -37.8×FY 2018: -43.7×FY 2019: -43.0×FY 2020: -38.1×FY 2021: -76.6×FY 2022: -22.6×FY 2023: -29.3×FY 2024: -11474×FY 2025: -12.3×FY 2026: -59.9×
FY 2017 5y median -29.3× FY 2026
P/S 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×FY 2026: 0.0×
FY 2017 5y median 0.0× FY 2026
P/B 12.9×
FY 2017: -22439×FY 2018: -247×FY 2019: -98.6×FY 2020: 143×FY 2021: -442×FY 2022: 465×FY 2023: -219×FY 2024: -1421×FY 2025: 3.0×FY 2026: 12.9×
FY 2017 5y median 3.0× FY 2026
P/FCF -42.3×
FY 2017: -39.4×FY 2018: -49.7×FY 2019: -58.5×FY 2020: -31.6×FY 2021: -66.2×FY 2022: -22.8×FY 2023: -33.4×FY 2024: -24.4×FY 2025: -11.6×FY 2026: -42.3×
FY 2017 5y median -24.4× FY 2026
EV/EBITDA -58.7×
FY 2017: -37.6×FY 2018: -44.9×FY 2019: -48.1×FY 2020: -40.4×FY 2021: -67.9×FY 2022: -22.6×FY 2023: -29.1×FY 2024: 26640×FY 2025: -9.3×FY 2026: -58.7×
FY 2017 5y median -22.6× FY 2026
EV/Sales 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×FY 2026: 0.0×
FY 2017 5y median 0.0× FY 2026
FCF Yield -2.4%
FY 2017: -2.5%FY 2018: -2.0%FY 2019: -1.7%FY 2020: -3.2%FY 2021: -1.5%FY 2022: -4.4%FY 2023: -3.0%FY 2024: -4.1%FY 2025: -8.6%FY 2026: -2.4%
FY 2017 5y median -4.1% FY 2026

Profitability

Gross Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026
Operating Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026
Net Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026
ROE -23.6%
FY 2017: 59170.6%FY 2018: 564.8%FY 2019: 229.4%FY 2020: -375.3%FY 2021: 577.0%FY 2022: -2057.4%FY 2023: 745.3%FY 2024: 10.3%FY 2025: -32.3%FY 2026: -23.6%
FY 2017 5y median -23.6% FY 2026
ROIC -19.8%
FY 2017: 60270.6%FY 2018: 559.1%FY 2019: 228.3%FY 2020: -273.6%FY 2021: -433.1%FY 2022: -217.3%FY 2023: 748.6%FY 2024: 10.4%FY 2025: -31.6%FY 2026: -19.8%
FY 2017 5y median -19.8% FY 2026
ROA -17.3%
FY 2017: -459.9%FY 2018: -752.0%FY 2019: -800.6%FY 2020: -183.1%FY 2021: -197.7%FY 2022: -176.0%FY 2023: -611.3%FY 2024: -0.6%FY 2025: -26.7%FY 2026: -17.3%
FY 2017 5y median -26.7% FY 2026

Growth (YoY)

Revenue 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 FY 2026
Operating Income 27.2%
FY 2017: -6.4%FY 2018: 16.7%FY 2019: 12.3%FY 2020: -14.7%FY 2021: -11.9%FY 2022: 32.0%FY 2023: 3.2%FY 2024: 99.9%FY 2025: -53256.1%FY 2026: 27.2%
FY 2017 FY 2026
EPS (diluted) 40.7%
FY 2017: 0.0%FY 2018: 21.5%FY 2019: 18.2%FY 2020: 0.3%FY 2021: 17.2%FY 2022: 24.7%FY 2023: 25.7%FY 2024: 99.7%FY 2025: -67300.0%FY 2026: 40.7%
FY 2017 FY 2026
Free Cash Flow -7.9%
FY 2017: -8.8%FY 2018: 21.7%FY 2019: 26.9%FY 2020: -95.9%FY 2021: 14.2%FY 2022: 30.0%FY 2023: 14.9%FY 2024: 5.5%FY 2025: 23.6%FY 2026: -7.9%
FY 2017 FY 2026

Financial Health

Current Ratio 0.2×
FY 2017: 0.8×FY 2018: 0.3×FY 2019: 0.2×FY 2020: 2.4×FY 2021: 1.0×FY 2022: 1.1×FY 2023: 0.5×FY 2024: 0.9×FY 2025: 0.1×FY 2026: 0.2×
FY 2017 5y median 0.5× FY 2026
Quick Ratio 0.2×
FY 2017: 0.8×FY 2018: 0.3×FY 2019: 0.2×FY 2020: 2.4×FY 2021: 1.0×FY 2022: 1.0×FY 2023: 0.5×FY 2024: 0.9×FY 2025: 0.1×FY 2026: 0.2×
FY 2017 5y median 0.5× FY 2026
Debt / Equity 0.3×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.1×FY 2021: -2.6×FY 2022: 7.7×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×FY 2026: 0.3×
FY 2017 5y median 0.0× FY 2026
Net Debt / EBITDA -1.1×
FY 2017: 0.1×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.5×FY 2021: -0.0×FY 2022: 0.1×FY 2023: 0.1×FY 2024: -227×FY 2025: -0.1×FY 2026: -1.1×
FY 2017 5y median -0.1× FY 2026
Interest Coverage -20.2×
FY 2017: -732×FY 2018: -294×FY 2019: -7489×FY 2020: -344×FY 2021: -641×FY 2022: -363×FY 2023: -452×FY 2024: -1.3×FY 2025: -503×FY 2026: -20.2×
FY 2017 5y median -363× FY 2026

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026

Annual · latest fiscal year ends 2026-07-31